Skip to main content
. 2015 Nov 24;5:16889. doi: 10.1038/srep16889

Figure 3. Kaplan-Meier curves of overall survival.

Figure 3

The expression of the NAMS predicts poor overall survival in the discovery (USA) and validation (JPN, SWE, and CAN) cohorts. The red curves are for the NAMS positive patients while the blue curves are for the NAMS negative patients. The NAMS positive patients were defined as those having a death risk score greater than zero. P-values were calculated by log-rank tests for the differences in survival between the NAMS positive and negative groups.